Earnings
CASI
1.530
-4.38%
-0.070
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
57.06M
9.31M
--
4.64M
--
--
0.00
--
1.36M
--
1.65M
0.00
74.03M
10.76M
--
29.44M
--
--
13.21M
--
299.00K
53.71M
127.73M
--
3.67M
1.29M
--
--
--
--
--
3.02M
--
--
--
--
7.98M
0.00
--
--
--
16.18M
38.22M
24.16M
1.24M
658.25M
-570.50M
-8.03M
--
22.03M
81.54M
103.57M
127.73M
FY 2019-12-31
53.62M
625.00K
--
1.29M
--
--
0.00
--
4.54M
--
1.42M
--
61.50M
9.69M
--
14.04M
--
--
16.89M
--
504.00K
41.13M
102.63M
--
5.11M
0.00
--
--
--
--
--
2.83M
--
--
--
--
7.95M
0.00
--
--
--
1.02M
21.69M
8.97M
979.00K
606.69M
-523.91M
-8.03M
--
20.67M
73.00M
93.67M
102.63M
FY 2018-12-31
84.20M
912.20K
--
--
--
--
0.00
--
--
--
7.45M
--
92.56M
1.75M
--
--
--
--
18.78M
--
310.02K
20.85M
113.41M
--
968.05K
1.50M
--
--
--
--
--
1.41M
--
--
--
--
3.87M
0.00
--
--
--
73.59K
73.60K
3.95M
953.67K
596.71M
-478.94M
-8.03M
--
--
109.46M
109.46M
113.41M
FY 2017-12-31
43.49M
--
--
--
--
--
0.00
--
--
--
322.49K
--
43.81M
1.05M
--
--
--
--
--
--
242.02K
1.29M
45.10M
--
4.32M
0.00
--
--
--
--
--
745.96K
--
--
--
--
5.06M
1.50M
--
--
--
0.00
1.50M
6.56M
699.02K
498.58M
-452.70M
-8.03M
--
--
38.54M
38.54M
45.10M
FY 2016-12-31
27.09M
--
--
--
--
--
0.00
--
--
--
355.89K
--
27.45M
229.59K
--
--
--
--
--
--
34.49K
264.08K
27.71M
--
1.06M
0.00
--
--
--
--
--
250.95K
--
--
--
--
1.32M
1.49M
--
--
--
4.12M
5.61M
6.93M
602.76K
470.15M
-441.93M
-8.03M
--
--
20.78M
20.78M
27.71M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CASI latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze CASI Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.